Newsletter Current page: 2

In a mini-series, SHS discussed how buy-and-build strategies can be developed and implemented in the healthcare sector with its portfolio companies as part of its portfolio workshops and internally with its colleagues as part of the SHS Academy.The workshops were supported by Valerie Rinecker, Managing Director of Altenried Etti & Co, an investment banking boutique […]

Verena Schiller has been appointed as the new Chief Executive Officer of Tyromotion GmbH. She brings global sector expertise and twenty years of experience in medical technology, particularly in the field of neurosurgery and radiotherapy. In previous roles, her focus was strongly on sales and internationalisation – one of the core growth drivers for Tyromotion […]

The Swiss SHS portfolio company TRI Dental Implants has successfully entered the US market as a direct market. This step enables the company bring its pioneering digital dental solutions directly to American customers. With a dedicated local team, important partnerships have been established and the sales structure has been successfully set up. This marks another […]

CoreMedic has appointed a new Chairwoman of the Board for the company. Jodi Akin is a healthcare leader and innovator. She has more than 25 years of experience in clinical development, scientific and regulatory strategy, and the management and development of the medical device market. With her impressive track record, she will bring critical expertise […]

SHS portfolio company Simulands, based in Zurich, has unveiled a ground-breaking portable and ultra-lightweight medical simulator simuGO, designed to enhance product demonstrations in the cardiology field. This innovative device, which can be set up in just 20 seconds, enables on-the-go and in-office demonstrations, significantly improving engagement and understanding of innovative and complex cardiology medical technology […]

Thomas Kraft has been appointed as the new Chief Executive Officer of SIS Medical AG. He has held this position since the beginning of September. Mr Kraft has over 20 years of global experience in the MedTech sector and brings a track record of strategic growth and operational excellence to SIS Medical. His background uniquely […]

Too often, interfaces between SMEs and private equity funds such as SHS are focused on transactions. But in the course of our normal business activities with more than 20 healthcare portfolio companies and more than 900 investment audits per year open up further opportunities beyond transaction: • Numerous board seats to be filled in our […]

On March 6, the SHS Academy was once again held at SHS Capital office in Tübingen. This informative learning format is designed to give all SHS employees as well as current and former trainees the opportunity to learn more about selected topics. In addition to various presentations by individual SHS professionals, an external speaker is […]

SHS organised its first portfolio workshop of the year. This time the topic was “Cybersecurity and penetration testing”. Working in healthcare means working with the most sensitive data and therefore cyber security is a top priority for SHS Capital and its portfolio companies. We have Sebastian Schreiber, CEO of “Syss. The Pentest Experts” as one […]

In January, SHS Partner André Zimmermann and SHS Investment Manager Hannes Kempter travelled to San Francisco for the J.P. Morgen Conference. For the first time in a long time, the weather was kind to the conference and was pleasantly sunny instead of the usual rainy weather. The atmosphere at the conference was also not dampened […]

In December 2023, the Federal Institute for Drugs and Medical Devices (BfArM) extended the reimbursement of Selfapy’s online course for generalised anxiety disorder to men. The BfArM thus confirms the results of additional real-world evidence (RWE), which shows that Selfapy’s product also significantly reduces anxiety symptoms and improves health-related quality of life in men with […]

At the end of 2023, the SHS portfolio company TRI received the SEF Growth High Potential Label from the Swiss Economic Forum. Founded in 2011, TRI began its journey with the goal of improving patient experience and outcomes with an innovative, digitalised approach to dental implantations. With TRI’s patented matrix implant technology – the world’s […]